Navigation Links
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Date:9/30/2013

elerate the development of OMS824 and recognizes the important work conducted at Omeros," stated Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "The manifestations of Huntington's are devastating to both Huntington's patients and their families, yet there is only one currently approved therapeutic and it is focused on a single symptom of the disease. OMS824 holds the promise of expanding treatment across the constellation of debilitating effects of Huntington's. We look forward to working with the FDA to advance the clinical evaluation of OMS824 in patients suffering from Huntington's disease and plan to initiate enrollment in a Phase 2 trial later this year."

About Omeros' PDE10 Program
PDE10 is an enzyme that is expressed in areas of the brain linked to diseases that affect cognition and psychomotor functions, including Huntington's disease and schizophrenia. Huntington's disease is a hereditary neurodegenerative disorder that leads to movement, cognition, and behavioral abnormalities and premature death. Schizophrenia is a group of severe brain disorders characterized by an abnormal interpretation of reality, which can manifest as delusions, hallucinations, and/or disordered thinking and behavior. Cognitive dysfunction is responsible for substantial disability in both of these diseases and is not meaningfully improved by current medications. Omeros' proprietary compound OMS824 inhibits PDE10 and is being developed for the treatment of cognitive disorders. In addition to potential benefits on cognition, OMS824 could also improve the motor and psychiatric abnormalities in Huntington's disease as well as the positive (e.g., hallucinations) and negative (e.g., flat affect) symptoms of schizophrenia.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics targeting inflam
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
2. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
3. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
4. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
5. FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
6. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
7. U.S. FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis Treatment
8. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
9. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
10. As Global Telemedicine Market Reaches $2.5 Billion, Industry Leaders Gather in San Diego to Discuss Grants, Funding, Vendor Selection, Credentialing, and More
11. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Mass. , Oct. 2, 2014  Alere Inc. (NYSE: ... announced today that the new E. HISTOLYTICA QUIK CHEK™ ... parasite, has received CE Mark for sale in international markets ... test is developed and manufactured by TECHLAB ® Inc. ... that infects an estimated 50 million people worldwide. Infected individuals ...
(Date:10/2/2014)... WOONSOCKET, R.I. , Oct. 2, 2014 ... Health Research Institute entitled, " Adherence: why it,s so ... reviews the Company,s key research findings on medication adherence ... five to 15 percent through new interventions by 2017. ... Institute has been focused on building the body of ...
(Date:10/2/2014)... , Oct. 2, 2014  MinuteClinic, the largest and fastest ... States , has opened its first walk-in clinics in the ... stores in Corpus Christi and ... Corpus Christi in December. The clinics are ... nationwide in 2014. With the Corpus Christi -area ...
Breaking Medicine Technology:Entamoeba histolytica Rapid Test Receives CE Mark 2CVS Health Insights Report Tackles Complex Issue of Medication Adherence 2CVS Health Insights Report Tackles Complex Issue of Medication Adherence 3First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 2First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 3
... Attorneys representing a group of U.S. citizens suffering from ... thalidomide have filed a lawsuit in federal court to compel ... drug was widely distributed in the United States. ... to a number of Freedom of Information Act (FOIA) requests ...
... of brand drug "copay coupon" promotions, which lure insured ... costs by $1.8 billion in Pennsylvania over the next ... to new research from Visante and released by the ... of these promotions by state and local government workers ...
Cached Medicine Technology:Hagens Berman: Patients Seek to Force FDA to Release Records Showing US Distribution of Thalidomide 2Hagens Berman: Patients Seek to Force FDA to Release Records Showing US Distribution of Thalidomide 3Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $1.8 Billion in Pennsylvania 2
(Date:10/2/2014)... October 02, 2014 The Business ... 2014 BIG Awards for Business program. The BIG ... with a proprietary judging process scored by well-known ... globe. , “The winners this year epitomize what ... Managing Director of the Business Intelligence Group. “The ...
(Date:10/2/2014)... October 02, 2014 BamboofloorChina.com is a ... products have won great appreciation from the global customers ... working hard to make more excellent items. All its ... to help all clients. , The company has ... to its website. Furthermore, the company’s marketing specialist ...
(Date:10/2/2014)... Maureen Salamon HealthDay Reporter ... Middle-aged women with a neurotic personality style and prolonged ... disease, new research suggests. Tracking 800 women over ... were most anxious, jealous and moody -- which they ... double the risk of developing Alzheimer,s compared to women ...
(Date:10/2/2014)... Oct. 1, 2014 (HealthDay News) -- Genes may interact with ... study suggests. The genetic risk occurs in about 13 ... The finding could help these people reduce their heart disease ... diet and stress management, the Duke University researchers said. ... and found a strong link between variations in the EBF1 ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. ... highway may raise your risk for high blood pressure, a ... those who lived within 109 yards of a busy road ... pressure than women living at least half a mile away, ... the importance of our physical environment on our health and ...
Breaking Medicine News(10 mins):Health News:Innovation Dominant Theme among 2014 Big Awards for Business Winners and Finalists 2Health News:High Quality Bamboo Panels Online At BamboofloorChina.com 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 3Health News:Genes May Make Some More Prone to Heart Disease When Under Stress 2Health News:Living Near a Highway May Be Bad for Your Blood Pressure 2Health News:Living Near a Highway May Be Bad for Your Blood Pressure 3
... U.S. Senate to vote soon on legislation that ... Minnesota, WASHINGTON, July 9 Seniors across ... Medicare Advantage program in,legislation being considered in the ... million from the Medicare Advantage program in,Minnesota alone ...
... support medical care for the uninsured, human,services, and ... Blue Cross and Blue Shield,of Illinois (BCBSIL) ... in Illinois. In line with its mission, "to ... communities through accessible,cost-effective, quality health care," BCBSIL,s giving ...
... the University of Alabama at Birmingham (UAB) have been ... The project is a national consortium of cutting-edge hospitals ... for patients with a kind of malignant brain tumor ... consortium, UAB will serve as the only research site ...
... Fans Can ,Start Their Engines, and Nominate Now at ... ... trusted brands,for indigestion and heartburn relief, is launching a nationwide search for,one ... 500 Sprint,Cup Series race at Martinsville Speedway in Martinsville, Va. on October,19, ...
... Daniel Von Hoff, a member of President ... in-depth look at "The Complete Phase Ib," ... rapid accrual rates, substantial economies of scale, ... patients, and improved therapeutic benefits. The ...
... ARLINGTON, Va., July 9 The HealthCentral,Network, ... new online medical and peer-to-peer resource,committed to ... about,drugs, surgeries and nutrition, along with offering ... Three expert writers, University of Pennsylvania clinical ...
Cached Medicine News:Health News:Minnesota Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Blue Cross and Blue Shield of Illinois Gives $960,000 in Charitable Donations 2Health News:Blue Cross and Blue Shield of Illinois Gives $960,000 in Charitable Donations 3Health News:UAB joins elite brain cancer research group 2Health News:TUMS Announces Nationwide Search for Grand Marshal at TUMS QuikPak 500 2Health News:Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit 2Health News:Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit 3Health News:Responding to Increased Incidence of Obesity and Associated Health Issues, The HealthCentral Network Launches Site to Support those Struggling with Weight 2
This double-up gel dryer system, 100-120 V, includes 2 Model 583 gel dryers, HydroTech™ vacuum pump, and double-up rack....
... GelAir™ drying system utilizes a hot air drying ... dried on a clear cellophane support for easy ... a smooth, flat assembly surface for the drying ... frames at once. This 115 V, 60 Hz ...
... dryer is an electrophoresis gel vacuum dryer that ... dries these gels onto cellophane or filter paper ... elements which heat gels from above. The drying ... V unit includes power cord, porous gel support, ...
... The PRO6000 power supply ... Thermo's power supply product offering. ... proteomic and genomic electrophoresis. This ... to proteomic applications such as ...
Medicine Products: